Citadel Advisors
MDXH icon

Citadel Advisors’s MDxHealth MDXH Stock Holding History

Citadel Advisors’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Buy
509,674
+450,040
+755% +$604K ﹤0.01% 11967
2026
Q1 		$137K Sell
59,634
-35,478
-37% -$120K ﹤0.01% 11759
2025
Q4 		$340K Buy
95,112
+46,174
+94% +$182K ﹤0.01% 9875
2025
Q3 		$228K Buy
48,938
+11,456
+31% +$35.2K ﹤0.01% 10974
2025
Q2 		$82.8K Buy
+37,482
New +$70.3K ﹤0.01% 11473
2025
Q1 		– Sell
-29,606
Closed -$70.2K – 15147
2024
Q4 		$70.2K Sell
29,606
-40,324
-58% -$82.4K ﹤0.01% 11964
2024
Q3 		$145K Buy
+69,930
New +$190K ﹤0.01% 10601
2023
Q3 		– Sell
-21,289
Closed -$72.6K – 14770
2023
Q2 		$72.6K Buy
+21,289
New +$77.8K ﹤0.01% 11349

Other funds holding MDXH

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors's MDXH Position: Q2 2026 in Review

Citadel Advisors increased its MDxHealth (MDXH) stake by 755% in Q2 2026, buying an estimated $604K and bringing the position to 509,674 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #11967.

Citadel Advisors first reported a position in MDXH in Q2 2023 and has held it in 8 quarters since. The position peaked at $340K in Q4 2025. 26 funds tracked by Wall St. Rank hold MDXH as of Q2 2026.

  • Citadel Advisors held 509,674 shares of MDxHealth worth $209K as of Q2 2026.
  • Citadel Advisors bought 450,040 MDxHealth shares in Q2 2026, an estimated $604K.
  • MDxHealth made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11967 holding.
  • Citadel Advisors first reported a position in MDxHealth in Q2 2023 and has held it in 8 quarters since.
  • Citadel Advisors's MDxHealth position peaked at $340K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MDxHealth as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.